Critically ill COVID-19 patients unlikely to benefit from convalescent plasma, early results from UK trial show
Convalescent plasma has no benefit for patients with COVID-19 who are severely ill and in intensive care, according to early findings from the ‘Randomised, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia’ trial.
Source link
- उद्यानिकी राज्य मंत्री (स्वतंत्र प्रभार) श्री कुशवाह - January 23, 2021
- AstraZeneca warns of limited vaccine supplies to Europe - January 23, 2021
- FDA Approves First Once-a-Month HIV Therapy, Cabenuva - January 23, 2021
- सारनी की खूबसूरती दिखेगी फिल्मी दुनिया में - January 23, 2021
- Belgium bans non-essential foreign trips from Wednesday - January 23, 2021
- For Maximum Effectiveness, De-Stress and Get Healthy Before Your COVID Shot - January 22, 2021
- मुख्यमंत्री श्री चौहान ने भजन गायक श्री चंचल के निधन पर शोक व्यक्त किया - January 22, 2021
- गैजेट का इस्तेमाल दिमागी और शारीरिक सेहत को करता है प्रभावित, इस तरह ले सकते हैं डिजिटल ब्रेक - January 22, 2021
- Study examines mono, chronic fatigue syndrome in college students - January 22, 2021
- For Rising Number of People, Obesity Is a Literal Headache - January 22, 2021
